Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges

This Special issue focuses of the most relevant advances in the field of inborn errors of immunity. Indeed, as immunology is rapidly progressing, with the constant discovery of new disease entities and the better characterization of molecular mechanisms and targeted therapies, a continuous update is...

Full description

Saved in:
Bibliographic Details
Other Authors: Consolini, Rita (Editor), Costagliola, Giorgio (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_112528
005 20230808
003 oapen
006 m o d
007 cr|mn|---annan
008 20230808s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-8309-9 
020 |a 9783036583082 
020 |a 9783036583099 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-8309-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a TB  |2 bicssc 
072 7 |a TCB  |2 bicssc 
100 1 |a Consolini, Rita  |4 edt 
700 1 |a Costagliola, Giorgio  |4 edt 
700 1 |a Consolini, Rita  |4 oth 
700 1 |a Costagliola, Giorgio  |4 oth 
245 1 0 |a Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (228 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This Special issue focuses of the most relevant advances in the field of inborn errors of immunity. Indeed, as immunology is rapidly progressing, with the constant discovery of new disease entities and the better characterization of molecular mechanisms and targeted therapies, a continuous update is mandatory for clinician and researchers. In this Issue, the non-infectious manifestations of inborn errors of immunity (such as autoimmunity, atopy, and lymphoproliferation) are deeply discussed, as well as the impact of the novel genetic sequencing techniques in the diagnostic approach. Moreover, some well-known disorders, including common variable immunodeficiency, are extensively reviewed and revisited in a modern way. Also, diseases of recent description, including some disorders of immune dysregulation and inborn errors of immunity associated with syndromes, are described. Finally, some of the papers of this Special Issue focus in a detailed way the molecular mechanisms leading to immunodeficiency and immune dysregulation, also opening the way for further clinical and preclinical studies. As the expanding availability of immunological and genetic testing offers the opportunity to identify new disease entities and elucidate the function of new genes involved in the development and regulation of the immune response, we aim to present the most relevant innovations in this delicate field. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Technology: general issues  |2 bicssc 
650 7 |a Biotechnology  |2 bicssc 
653 |a B cell maturation 
653 |a CD4+ cells 
653 |a T cell maturation 
653 |a primary immune deficiency 
653 |a autoimmunity 
653 |a connective tissue diseases 
653 |a atopic diseases 
653 |a atopy 
653 |a allergy 
653 |a selective IgA deficiency 
653 |a primary immunodeficiency 
653 |a autoimmune diseases 
653 |a Immunoglobulin E 
653 |a Immunoglobulin deficiency 
653 |a infections 
653 |a malignancy 
653 |a 22q11.2 deletion syndrome 
653 |a activated phosphoinositide 3-kinase d syndrome 
653 |a common variable immunodeficiency 
653 |a complement deficiency 
653 |a CTLA-4 
653 |a Immune dysregulation 
653 |a LRBA 
653 |a severe combined immunodeficiency 
653 |a X-linked agammaglobulinemia 
653 |a anti-SARS-CoV-2 antibodies 
653 |a COVID-19 
653 |a SARS-CoV-2 
653 |a PIMS-TS 
653 |a Foxp3 
653 |a IPEX 
653 |a CVID 
653 |a primary immunodeficiencies 
653 |a epigenetics 
653 |a DNA methylation 
653 |a inborn errors of immunity 
653 |a DiGeorge syndrome 
653 |a 22q11.2 deletion 
653 |a thymic output 
653 |a dendritic cells 
653 |a immunodeficiency 
653 |a copy number variations 
653 |a array-CGH 
653 |a IKZF1 
653 |a IKAROS 
653 |a de novo mutation 
653 |a R162Q 
653 |a immune response 
653 |a heterologous vaccine 
653 |a humoral response 
653 |a T-cell response 
653 |a autoimmune lymphoproliferative syndrome 
653 |a lymphoproliferation 
653 |a gastrointestinal infections 
653 |a Giardia 
653 |a giardiasis 
653 |a refractory 
653 |a treatment 
653 |a immunology 
653 |a immunogenetic 
653 |a eosinophilic gastrointestinal disorders 
653 |a eosinophilic esophagitis 
653 |a unclassified primary antibody deficiency 
653 |a primary antibody deficiency 
653 |a transient hypogammaglobulinemia of infancy 
653 |a children 
653 |a TNFRSF13B mutations 
653 |a isolated IgM deficiency 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/7654  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/112528  |7 0  |z DOAB: description of the publication